NCT03598309 2026-02-27
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan Rogel Cancer Center
University of Kansas Medical Center
Kyunghee University Medical Center
Vanderbilt University Medical Center
University of Kansas Medical Center
Columbia University